title: Treatment of autonomic failure.
abstract: The group of primary autonomic failure (AF) syndromes comprises pure AF (PAF), in which there are no central neurological signs, and multiple system atrophy (MSA) in which AF is accompanied by the overlapping degenerative disorders, striatonigral degeneration and olivopontocerebellar atrophy. Patients with these syndromes deteriorate progressively but, based on an understanding of the precise sites of the lesions, there are several ways of alleviating their deterioration, in particular the most disabling symptom, postural hypotension. The principles can be used in the treatment of AF in other general medical disorders, such as diabetes.
authors.affiliation: Department of Neurology, Radcliffe Infirmary, Oxford, UK.
authors.forename: R
authors.initials: R
authors.lastname: Bannister
mesh_terms: D001341:Autonomic Nervous System / Q000503:physiopathology; D001342:Autonomic Nervous System Diseases / Q000503:physiopathology / Q000628:therapy*; D003131:Combined Modality Therapy; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage; D005438:Fludrocortisone / Q000008:administration & dosage; D006801:Humans; D007024:Hypotension, Orthostatic / Q000503:physiopathology / Q000628:therapy*; D010138:Pacemaker, Artificial; D011187:Posture / Q000502:physiology
chemical_list: D003894:Deamino Arginine Vasopressin; D005438:Fludrocortisone